EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura

Muriel Meiring iD, Mmakgabu Khemisi, Susan Louw iD, Palanisamy Krishnan

Vox Sanguinis · 2024

DOI: 10.1111/vox.13738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Muriel Meiring und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. Hauptthemen laut MEDLINE: ADAMTS13 Protein, Purpura, Thrombotic Thrombocytopenic, Autoantibodies, HIV Infections. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal thrombotic microangiopathic disorder that can result from human immunodeficiency virus (HIV) infection. The pathogenesis involves a deficiency of the von Willebrand factor (vWF) cleaving protease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin motifs member 13) and the presence of anti‐ADAMTS13 autoantibodies. However, there is insufficient information regarding the epitope specificity and reactivity of these autoantibodies. This study aimed to perform epitope‐mapping analysis to provide novel insights into the specific epitopes on ADAMTS13 domains affected by autoantibodies. Materials and Methods The study analysed 59 frozen citrate plasma samples from HIV‐associated TTP patients in South Africa, measuring ADAMTS13 activity using Technozyme® ADAMTS13 activity test, total immunoglobulin (Ig) M and IgA antibodies levels using ELISA kit and purifying IgG antibodies using NAb™ Protein G spin columns. A synthetic ADAMTS13 peptide library was used for epitope mapping. Results Overall, 90% of samples showed anti‐ADAMTS13 IgG autoantibodies, with 64% of these antibodies being inhibitory, as revealed by mixing studies. Samples with ADAMTS13 antigen levels below 5% showed high anti‐ADAMTS13 IgG autoantibody titres (≥50 IU/mL), whereas those with 5%–10% levels had low autoantibody titres (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAMTS13 ProteinPurpura, Thrombotic ThrombocytopenicAutoantibodiesHIV InfectionsHumansMaleFemaleAdultImmunoglobulin GEpitope MappingMiddle Aged

Stichwörter der Autor:innen

ADAMTS13HIVautoantibodiesthrombotic thrombocytopenic purpura

Substanzen

ADAMTS13 ProteinAutoantibodiesADAMTS13 protein, humanImmunoglobulin G

Autor:innen und Institutionen

  • Department of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
  • Universitas Business Unit, National Health Laboratory Service, Bloemfontein, South Africa.
  • Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Muriel Meiring, Susan Louw

Förderung

  • National Research Foundation

Zitieren

APA

Meiring, M., Khemisi, M., Louw, S., & Krishnan, P. (2024). Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura. Vox Sanguinis. https://doi.org/10.1111/vox.13738

Vancouver

Meiring M, Khemisi M, Louw S, Krishnan P. Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura. Vox Sanguinis. 2024. doi:10.1111/vox.13738

BibTeX
@article{Meiring2024,
  author = {Meiring, Muriel and Khemisi, Mmakgabu and Louw, Susan and Krishnan, Palanisamy},
  title = {Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura},
  journal = {Vox Sanguinis},
  year = {2024},
  doi = {10.1111/vox.13738}
}
Kostenlos starten →